Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02423954
What this trial is testing

Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)

Who this might be right for
Advanced CancerPancreatic CancerRenal Cell Cancer+4 more
Western Regional Medical Center 33
Early research (Phase 1)Study completedNCT04580485
What this trial is testing

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

Who this might be right for
Ovarian CancerBladder CancerNon Small Cell Lung Cancer+8 more
Incyte Corporation 54
Not applicableUnknownNCT01482585
What this trial is testing

Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy

Who this might be right for
Lung Adenocarcinoma
Samsung Medical Center 200
Early research (Phase 1)Study completedNCT00659568
What this trial is testing

Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma

Who this might be right for
Breast CancerEndometrial CancerKidney Cancer+3 more
London Health Sciences Centre 28
Not applicableUnknownNCT00751543
What this trial is testing

The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy

Who this might be right for
AdenocarcinomaSquamous Cell CarcinomaRelevant Condition Terms to the Conditions Field
National Taiwan University Hospital 20
Early research (Phase 1)Study completedNCT00033410
What this trial is testing

Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
California Cancer Consortium 30
Testing effectiveness (Phase 2)Looking for participantsNCT07629960
What this trial is testing

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Who this might be right for
Advanced Solid TumorNon-Small Cell Lung CancerColorectal Neoplasms+1 more
Blueprint Medicines Corporation 265
Testing effectiveness (Phase 2)Looking for participantsNCT07223047
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

Who this might be right for
Advanced Solid MalignanciesNon-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+1 more
Bristol-Myers Squibb 252
Early research (Phase 1)Study completedNCT00926640
What this trial is testing

A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers

Who this might be right for
Carcinoma NeuroendocrineSmall Cell Lung CarcinomaMalignant Epithelial Neoplasms
National Cancer Institute (NCI) 28
Early research (Phase 1)Study completedNCT04853017
What this trial is testing

ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

Who this might be right for
Minimal Residual DiseaseKRAS G12DKRAS G12R+9 more
Elicio Therapeutics 25
Testing effectiveness (Phase 2)UnknownNCT00398385
What this trial is testing

Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
National Cancer Center, Korea 170
Early research (Phase 1)Looking for participantsNCT07623369
What this trial is testing

A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Huahui Health 299
Early research (Phase 1)UnknownNCT00024063
What this trial is testing

SU006668 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Looking for participantsNCT03198546
What this trial is testing

GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression

Who this might be right for
Hepatocellular CarcinomaImmunotherapyCAR+3 more
Second Affiliated Hospital of Guangzhou Medical University 30
Not applicableStudy completedNCT02127359
What this trial is testing

Whole-Exome Sequencing (WES) of Cancer Patients

Who this might be right for
Lung AdenocarcinomaColon Adenocarcinoma
Dana-Farber Cancer Institute 244
Not applicableLooking for participantsNCT06995898
What this trial is testing

The Vanguard Study: Testing a New Way to Screen for Cancer

Who this might be right for
Bladder CarcinomaBreast CarcinomaColorectal Carcinoma+8 more
National Cancer Institute (NCI) 24,000
Not applicableLooking for participantsNCT04981119
What this trial is testing

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Who this might be right for
Solid Tumor, AdultColorectal CancerNon Small Cell Lung Cancer+14 more
A2 Biotherapeutics Inc. 500
Testing effectiveness (Phase 2)Study completedNCT00227708
What this trial is testing

Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
UNICANCER 58
Not applicableNot Yet RecruitingNCT06645743
What this trial is testing

Retrospective Analysis of Clinical and CT Features to Predict Spread Through Air Space in Stage IA Lung Adenocarcinoma

Who this might be right for
Tomography, X-Ray ComputedSpread Through Air SpaceClinical Features+1 more
The Third Affiliated Hospital of Kunming Medical College. 1,100
Not applicableLooking for participantsNCT07485114
What this trial is testing

Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)Non Small Cell Lung CancerHepatocellular Carcinoma+1 more
Daniel Keizman 300
Next Page